Description
a) Primary prevention of coronary heart disease (CPC) and myocardial infarction (MI) in patients with hypercholesterolemia.
b) Dyslipidemias types IIa, IIb, and IV, according to the Fredrickson classification.
c) Treatment of other dyslipidemias: Fredrickson’s Types III and V. Associated with diabetes or xanthomas.
Gemfibrozil is indicated when exercise, weight reduction, and dietary or other non-pharmacological measures, such as limiting alcohol intake, have failed. Other medical conditions such as hypothyroidism and diabetes should be controlled as much as possible.
During treatment with Gemfibrozil, periodic determinations of serum lipids should be obtained. The drug should be discontinued or additional treatment should be instituted if the lipid response is inadequate after three months.
Reviews
There are no reviews yet.